GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
77.78
+0.93 (1.21%)
At close: Mar 13, 2026, 4:00 PM EDT
78.00
+0.22 (0.28%)
After-hours: Mar 13, 2026, 7:56 PM EDT
GeneDx Holdings Employees
GeneDx Holdings had 1,300 employees as of December 31, 2025. The number of employees increased by 300 or 30.00% compared to the previous year.
Employees
1,300
Change (1Y)
300
Growth (1Y)
30.00%
Revenue / Employee
$328,876
Profits / Employee
-$16,170
Market Cap
2.28B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,300 | 300 | 30.00% |
| Dec 31, 2024 | 1,000 | 0 | - |
| Dec 31, 2023 | 1,000 | -100 | -9.09% |
| Dec 31, 2022 | 1,100 | -100 | -8.33% |
| Dec 31, 2021 | 1,200 | 328 | 37.61% |
| Mar 31, 2021 | 985 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| RadNet | 9,276 |
| Sotera Health Company | 3,000 |
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| GRAIL | 1,000 |
| Twist Bioscience | 979 |
| Castle Biosciences | 883 |
| CareDx | 765 |
WGS News
- 1 day ago - Cathie Wood Just Bought This Small Cap Stock Seven Days Straight: Should Investors Take Note? - Benzinga
- 2 days ago - GeneDx Holdings Corp. (WGS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript - Seeking Alpha
- 2 days ago - Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing - Business Wire
- 3 days ago - GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C - Business Wire
- 4 days ago - GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership - Business Wire
- 16 days ago - HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 16 days ago - GeneDx to Participate in Upcoming Investor Conferences - Business Wire
- 17 days ago - These Analysts Slash Their Forecasts On GeneDx After Q4 Results - Benzinga